Gene · 8554
NIH grants1,276
NIH grants whose papers are about the gene, through NIH's grant-paper links.
101 to 120 of 1,276
Download this page as JSON| Grant | Title | PIAS1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI166313 | Dynamics of the cellular and molecular architecture of human pulmonary TB granulomas | 1 | 2025 |
| R01AI169728 | Virus-host interactions regulating innate signaling for human cytomegalovirus latency | 1 | 2025 |
| R01AI181865 | Metabolism and HCMV: determinants of the antiviral state | 1 | 2025 |
| R01AI187186 | ASB13 Control of EBV Life Cycle in B Cell and Epithelial Cell Cancers | 1 | 2025 |
| R01AR041398 | Novel Molecular Biomarkers of Bone Microarchitecture | 1 | 2025 |
| R01AR045192 | REGULATORS OF EPIDERMAL GENE EXPRESSION | 1 | 2025 |
| R01AR045203 | D4Z4 Coding Transcripts and FSHD | 1 | 2025 |
| R01AR046713 | Cytokine regulation of RA synoviocyte phenotype | 1 | 2025 |
| R01AR050401 | Cytokine Balance in Rheumatoid Arthritis | 1 | 2025 |
| R01CA073764 | FEN1-mediated Okazaki fragment maturation and its deficiency in cancer | 1 | 2025 |
| R01CA129933 | Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor Cells | 1 | 2025 |
| R01CA184984 | Maximizing the predictive power of high-throughput, microscopy-based phenotypic screens | 1 | 2025 |
| R01CA193837 | Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence | 1 | 2025 |
| R01CA214872 | Parp Function in Prostate Cancer | 1 | 2025 |
| R01CA238249 | Integrated ligand and target discovery by chemical proteomics for glioblastoma treatment. | 1 | 2025 |
| R01CA244261 | Mechanistic characterization of the cell cycle-dependent DNA repair pathway- Resubmission | 1 | 2025 |
| R01CA248037 | Regulation of oncogenic Akt ubiquitination and activation by diverse mechanisms in cancer | 1 | 2025 |
| R01CA251555 | Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches | 1 | 2025 |
| R01CA256543 | Targeting Constitutively Active SUMO Modified Androgen Receptors in Endocrine Resistant Breast Cancer | 1 | 2025 |
| R01CA262577 | Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8554/grants?page=6